Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NuvaRing Effects on Vaginal Biomarkers
NCT01448291Phase 4Unknown
- Sponsor
- Eastern Virginia Medical School
- Start
- Oct 2011
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of etonogestrel + ethinyl estradiol in pregnancy, sponsored by Eastern Virginia Medical School. Primary endpoint: Concentrations of vaginal innate and inflammatory biomarkers at 3 months. Status: unknown.
02
Drugs
etonogestrel + ethinyl estradiol
03
Conditions
pregnancy
Beyond the preview
Go deeper on NCT01448291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01448291.